Delian Capital
德联资本
Delian Capital (德联资本) is a Chinese venture capital firm that appears in elsewhere's corpus primarily as a co-investor alongside other funds in early-stage rounds. The bundle shows it participating in Tapdata's Pre-A+ round in July 2021, alongside XVC and following 5Y Capital's lead in the Pre-A , and in Aikai Biotech's rapid fundraising sequence in 2021-2022 alongside 5Y Capital, West Lake Innovation Investment, and others . Elsewhere's corpus does not contain a dedicated profile or description of Delian Capital's own investment thesis, fund size, or founding details.
AI-generated — may contain errors, please verify.
Coverage
"Green Carbon Synthetic Energy" Closes Tens of Millions of RMB in Pre-A Funding, Linear Capital Continues to Double Down | Linear Portfolio
Its first self-operated factory will have an annual production capacity of 1,000 metric tons of SAF upon completion.
线性资本·April: Imagination Is the Courage with Which We Face the World | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Aikai Biotech Completes Three Funding Rounds in Its First Year
Innovate from the source.
五源资本·As Fierce as August | 5Y News Monthly
The big news from last month.
五源资本·5Y News | "Tapdata Secures Tens of Millions of USD Across Two Consecutive Rounds, Carving Out a New Track in Real-Time Data Services"
Building a real-time data service platform for TP operations.
五源资本·
